Rapport Therapeutics’ cover photo
Rapport Therapeutics

Rapport Therapeutics

Biotechnology Research

Precision medicines to match the complexity of the human brain.

About us

Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.

Website
http://www.rapportrx.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Boston, Massachusetts
Type
Privately Held
Founded
2022

Locations

Employees at Rapport Therapeutics

Updates

Similar pages

Browse jobs

Funding